RTCA’s writ petition on Tax Audit extension has been accepted by the Hon’ble Rajasthan HC. Notices have been served to CBDT, with the next hearing on 25 September 2026.
But why wait? CBDT should extend the due date to 31.10.2026 before the hearing itself.
#ExtendTaxAuditDate
Dear CBDT,
Please extend the Tax Audit due date to 31.10.2026 at the earliest.
More time means better verification, quality compliance and less pressure on taxpayers and tax professionals.
Please announce the extension now. 🙏
#ExtendTARDueDate#Extension_हक़_है_भीख_नहीं
ICAI should listen to its members and the repeated representations from tax professionals across India and act on the Tax Audit due-date extension.
The profession needs a clear, timely and practical response from ICAI. 🙏
#Extend_due_date_now#ExtendTARDueDate
The most expensive part of a hospital bill may never touch the hospital at all.
A patient admitted for care has no way of knowing whether the price on a medical consumable reflects its actual cost or a markup fixed long before it ever reached the ward. That gap in information is, at its core, a public health issue.
A survey of hospital consumables in Maharashtra found an IV infusion set with a trade price of ₹11.05 carrying a printed MRP of ₹325 ; a markup of 2,841%. A syringe procured at ₹6.75 carried an MRP of ₹57.20. A catheter procured at ₹29.41 carried an MRP of ₹310.
These are not elective purchases. Patients cannot compare prices, seek alternatives, or question a number printed on a box while receiving care and the MRP itself is often fixed upstream by manufacturers and distributors, disconnected from the trade price by a wide, unexplained margin. The result is a system where the party bearing the cost has the least information to evaluate it.
The regulatory gap is structural: scheduled medicines are capped under the Drugs (Prices Control) Order, 2013. Most medical devices and consumables are not leaving both the pricing and the information around it almost entirely unmonitored.
A review of these findings and clear guidelines on the permissible gap between trade procurement price and declared MRP have been recommended to the Department of Pharmaceuticals and the NPPA ; a step toward closing not just a pricing gap, but the information gap patients are left to bear alone.
#PublicHealth #GoodGovernance #Leadership #TukaramMundhe
https://t.co/Ye9CVzr8qU
One bad policy can hurt an entire industry.
India’s sugar and rice markets are facing rising pressure. If E20 is creating unintended consequences, the government should review the policy objectively—not protect investments at the cost of farmers and consumers.
The Income Tax e-filing portal is not working , causing inconvenience to taxpayers and professionals. Kindly extend the ITR due date so taxpayers are not affected by technical issues.
@IncomeTaxIndia#ExtendITRDueDate#ITR
The Income Tax e-filing portal is not working properly, causing inconvenience to taxpayers and professionals. Kindly extend the ITR due date so taxpayers are not affected by technical issues.
@IncomeTaxIndia#ExtendITRDueDate#ITR